Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype

Cell and Tissue Research

Volumn 343, Issue 3, 2011, Pages 545-558

  Wu, Li An ^a,b   Feng, Junsheng ^a,c   Wang, Lynn ^a   Mu, Yan Dong ^a   Baker, Andrew ^a   Donly, Kevin J ^a   Harris, Stephen E ^a   MacDougall, Mary ^d   Chen, Shuo ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Floxed Bmp2; Gene expression; Immortalization; Osteoblast; SV40 T Ag

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BONE MORPHOGENETIC PROTEIN 2; CRE RECOMBINASE; DENTIN MATRIX PROTEIN 1; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; SIALOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX3; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENOTYPE; IMMUNOHISTOCHEMISTRY; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; GENOTYPE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; PHENOTYPE;

EID: 79953832903     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-010-1120-3     Document Type: Article

References (70)

1. Ameri K, Harris AL (2008) Activating transcription factor 4. Int J Biochem Cell Biol 40:14-21 (Pubitemid 350064577)
2. Aubin JE, Liu F (1996) In principles of bone biology. Academic, San Diego, pp 51-67
3. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS (1996) The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J 15:2236-2248 (Pubitemid 26141140)
4. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, Tabin CJ (2006) Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2:2116-2130
5. Bax BE, Wozney JM, Ashhurst DE (1999) Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 65:83-89 (Pubitemid 29293533)
6. Bodine PV, Trailsmith M, Komm BS (1996) Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 11:806-819 (Pubitemid 26172805)
7. Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M (2008) A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res 68:9488-9496
8. Chen H, Campisi J, Padmanabhan R (1996) SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J Biol Chem 271:13959-13967 (Pubitemid 26190285)
9. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233-241 (Pubitemid 40136452)
10. Chen S, Rani S, Wu Y, Unterbrink A, Gu TT, Gluhak-Heinrich J, Chuang HH, Macdougall M (2005) Differential regulation of dentin sialophosphoprotein expression by Runx2 during odontoblast cytodifferentiation. J Biol Chem 280:29717-29727 (Pubitemid 41177049)
11. Chung CY, Iida-Klein A, Wyatt LE, Rudkin GH, Ishida K, Yamaguchi DT, Miller T (1999) Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Biochem Biophy Res Commun 265:246-251
12. Damania B, Alwine JC (1996) TAF-like function of SV40 large T antigen. Genes Dev 10:1369-1381 (Pubitemid 26260716)
13. Darimont C, Avanti O, Tromvoukis Y, Vautravers-Leone P, Kurihara N, Roodman GD, Colgin LM, Tullberg-Reinert H, Pfeifer AM, Offord EA, Mace K (2002) SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype. Cell Growth Differ 13:59-67 (Pubitemid 34205513)
14. Dong J, Amor D, Aldred MJ, Gu T, Escamilla M, MacDougall M (2005) DLX3 mutation associated with autosomal dominant amelogenesis imperfecta with taurodontism. Am J Med Genet A 133A:138-141 (Pubitemid 40279779)
15. Divieti P, Lanske B, Kronenberg HM, Bringhurst FR (1998) Conditionally immortalized murine osteoblasts lacking the type1 PTH/PTHrP receptor. J Bone Miner Res 13:1835-1845 (Pubitemid 28535840)
16. Ducy P, Karsenty G (2000) The family of bone morphogenetic proteins. Kidney Int 57:2207-2214 (Pubitemid 30340719)
17. Ducy P, Zhang MR, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754 (Pubitemid 27516177)
18. Duverger O, Lee D, Hassan MQ, Chen SX, Jaisser F, Lian JB, Morasso MI (2008) Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome. J Biol Chem 283:20198-20208
19. Fei Y, Xiao L, Hurley MM (2010) Fibroblast growth factor 2 positively regulates expression of activating transcription factor 4 in osteoblasts. Biochem Biophys Res Commun 391:335-339
20. Franceschi RT, Ge C, Xiao G, Roca H, Jiang D (2007) Transcriptional regulation of osteoblasts. Ann NY Acad Sci 1116:196-207 (Pubitemid 350274351)
21. Gagneten S, Le Y,Miller J, Sauer B (1997) Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of sitespecific genomic deletions. Nucleic Acids Res 25:3326-3331 (Pubitemid 27338694)
22. Galler KM, Schweikl H, Thonemann B, D'Souza RN, Schmalz G (2006) Human pulp-derived cells immortalized with Simian Virus 40 T-antigen. Eur J Oral Sci 114:138-146 (Pubitemid 43480636)
23. Gannon JV, Lane DP (1987) p53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature 329:456-458 (Pubitemid 17128318)
24. Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2006) BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem 281:40515-40526 (Pubitemid 46041853)
25. Herzig M, Novatchkova M, Christofori G (1999) An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumori-genesis. Biol Chem 380:203-211 (Pubitemid 29118842)
26. Hoffman BE, Newman-Tarr TM, Gibbard A, Wang S, Hanning C, Pratta MA, Boyle RJ, Kumar S, Majumdar MK (2010) Development and characterization of a human articular cartilage-derived chondrocyte cell line that retains chondrocyte phenotype. J Cell Physiol 222:695-702
27. Hogan BL (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594
28. Iwata T, Yamakoshi Y, Simmer JP, Ishikawa I, Hu JC (2007) Establishment of porcine pulp-derived cell lines and expression of recombinant dentin sialoprotein and recombinant dentin matrix protein-1. Eur J Oral Sci 115:48-56
29. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2008) Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283:8412-8422
30. Karsenty G (2008) Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9:183-196
31. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T (1990) The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299 (Pubitemid 20352535)
32. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764 (Pubitemid 27516178)
33. Kubler NR, Reuther JF, Faller G, Kirchner T, Ruppert R, Sebald W (1998) Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg 27:305-309 (Pubitemid 128364308)
34. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G (1997) Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16:307-310 (Pubitemid 27280218)
35. Lee KY, Jeong JW, Wang J, Ma L, Martin JF, Tsai SY, Lydon JP, DeMayo FJ (2007) Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27:5468-5478 (Pubitemid 47124399)
36. Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA (1990) The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396
37. Ma L, Martin JF (2005) Generation of a Bmp2 conditional null allele. Genesis 42:203-206 (Pubitemid 41099679)
38. Ma L, Lu MF, Schwartz RJ, Martin JF (2005) Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132:5601-5611 (Pubitemid 43125885)
39. Marie PJ (1998) In advances in organ biology. JAI, Stamford, pp 445-473
40. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125
41. Matsuda T, Cepko CL (2007) Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci USA 104:1027-1032 (Pubitemid 46154730)
42. Michalovitz D, Eliyahu D, Oren M (1986) Overproduction of protein p53 contributes to simian virus 40-mediated transformation. Mol Cell Biol 6:3531-3536
43. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779 (Pubitemid 27516180)
44. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29 (Pubitemid 34137009)
45. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771 (Pubitemid 27516179)
46. Park GT, Morasso MI (2002) Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes. Nucleic Acids Res 30:515-522 (Pubitemid 34679613)
47. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R (1992) The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor. Mol Cell Biol 12:5069-5077
48. Price JA, Bowden DW, Wright JT, Pettenati MJ, Hart TC (1998) Identification of a mutation in DLX3 associated with trichodento-osseous (TDO) syndrome. Hum Mol Genet 7:563-569 (Pubitemid 28120650)
49. Quack I, Vonderstrass B, Stock M, Aylsworth AS, Becker A, Brueton L, Lee PJ, Majewski F, Mulliken JB, Suri M, Zenker M, Mundlos S, Otto F (1999) Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet 65:1268-1278 (Pubitemid 30460377)
50. Reddi AH (1997) Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8:11-20
51. Rivera-Feliciano J, Tabin CJ (2006) Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev Biol 295:580-588 (Pubitemid 43927695)
52. Rosen V (2009) BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20:475-480
53. Royzman I, Whittaker AJ, Orr-Weaver TL (1997) Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program. Genes Dev 11:1999-2011 (Pubitemid 27332986)
54. Singh AP, Castranio T, Scott G, Guo D, Harris MA, Ray M, Harris SE, Mishina Y (2008) Influences of reduced expression of maternal bone morphogenetic protein 2 on mouse embryonic development. Sex Dev 3:134-141
55. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M (1996) Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593-629 (Pubitemid 26163716)
56. Takeshita S, Arai S, Kudo A (2001) Identification and characterization of mouse bone marrow stromal cell lines immortalized by temperature-sensitive SV40 T antigen: supportive activity for osteoclast differentiation. Bone 29:236-241 (Pubitemid 32823566)
57. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K (1991) Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174:96-101
58. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424-1429 (Pubitemid 44837565)
59. Ulsamer A, Ortuño MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F (2008) BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 283:3816-3826
60. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
61. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, Li XJ (1998) Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13:1483-1490 (Pubitemid 28418916)
62. Winn SR, Randolph G, Uludag H, Wong SC, Hair GA, Hollinger JO (1999) Establishing an immortalized human osteoprecursor cell line: OPC1. J Bone Miner Res 14:1721-1733 (Pubitemid 29455821)
63. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz R, Hewick R, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534 (Pubitemid 19023695)
64. Wright JT, Hong SP, Simmons D, Daly B, Uebelhart D, Luder HU (2008) DLX3 c.561-562delCT mutation causes attenuated phenotype of tricho-dento-osseous syndrome. Am J Med Genet A 146:343-349 (Pubitemid 351212835)
65. Wu XB, Schneider A, Yu W, Rajendren Iqbal GJ, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E (2003) Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 112:924-993
66. Wu LA, Yuan G, Yang G, Ortiz-Gonzalez I, Yang W, Cui Y, MacDougall M, Donly KJ, Harris S, Chen S (2009) Immortalization and characterization of mouse floxed Bmp2/4 osteoblasts. Biochem Biophys Res Commun 386:89-95
67. Xiao G, Jiang D, Ge C, Zhao Z, Lai Y, Boules H, Phimphilai M, Yang X, Karsenty G, Franceschi RT (2005) Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem 280:30689-30696 (Pubitemid 41291797)
68. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687 (Pubitemid 21926024)
69. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117:387-398 (Pubitemid 38534544)
70. Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986 (Pubitemid 26371964)